Page 3 - Tobacco Program News Today

Have certain needs that can be filled by people with disabilities . As that process like what is that process like . We learned a lot of useful information. For us, it is going beyond just focusing on people with disabilities to try to get into what all of us are focused on, workforce development. We are over and over again from employers that there are jobs available, but there are skills gaps, and to the extent that we can plug in people with disabilities who may have expertise, either fulltim...

UC Davis Comprehensive Cancer Center has launched the state’s first-ever Tobacco Cessation Policy Research Center.

MICHIGAN CITY — Breathe Easy La Porte County, in its mission reduce the health and economic impact of tobacco in the community, is joining the fight against lung cancer on

Recent Freedom of Information Act (FOIA) litigation raises an interesting question: When federal agency action requires analyses under a holistic, multi-factor statutory standard, may...

Reagan-Udall Report of Center for Tobacco Products, notes that CTP’s role is not only protection via regulation but also via educating the public, especially young people. CTP is initiating the development of a comprehensive 5-year strategic plan.

Oregon’s U.S. Senator Jeff Merkley led 21 senators in a letter to the Food and Drug Administration (FDA) Commissioner Robert Califf, urging the FDA to promptly finalize its April 28,

Appalachian Research Day, also known as "Come Sit on the Porch," is an annual conference hosted by the University of Kentucky Center of Excellence in Rural Health (UK CERH) to

President Biden and Vice President Harris give remarks at event celebrating Black History Month. Vice President Harris to give remarks about affordable high-speed internet access. White House observes one year anniversary of Russia's invasion of Ukraine.

/PRNewswire/ -- Today, the U.S. Food and Drug Administrations Center for Tobacco Products (CTP) outlined the steps it plans to take in response to an external...

The Reagan-Udall Foundation engaged an independent expert panel to evaluate the operational aspects of the U.S. Food and Drug Administration's (FDA)